Lilly selects Veeva CRM for global deployments

Veeva Systems announced today that its Veeva CRM^® suite of applications has been chosen by pharmaceutical company Eli Lilly and Company for major global deployments.

“Implementing Veeva CRM will help Lilly streamline operations on a global basis, increase agility, and focus our interactions to the unique needs of health care providers”

Over the past three years, Veeva has quickly become a leading provider of Pharma CRM systems globally. Its multi-tenant SaaS architecture provides customers with a solution that is more functional, flexible, and usable than traditional alternatives. In addition, all Veeva customers benefit from free, automatic upgrades so users are always on the latest version of the software, aiding in regulatory compliance while enhancing overall system performance.

"We are excited to enter into this partnership with Eli Lilly and Company," said Peter Gassner, president and CEO of Veeva Systems. "We feel our products and services will help Lilly increase the efficiency and effectiveness of its customer facing teams."

"Implementing Veeva CRM will help Lilly streamline operations on a global basis, increase agility, and focus our interactions to the unique needs of health care providers," stated Michael Heim, chief information officer at Lilly.